Filing Details

Accession Number:
0001127602-23-010145
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-14 19:05:46
Reporting Period:
2023-03-12
Accepted Time:
2023-03-14 19:05:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531048 Inari Medical Inc. NARI Surgical & Medical Instruments & Apparatus (3841) 452902923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644989 Hill, Mitch C. C/O Inari Medical, Inc.
6001 Oak Canyon
Irvine CA 92618
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-12 125,393 $0.00 193,285 No 4 M Direct
Common Stock Acquisiton 2023-03-13 6,500 $0.46 199,785 No 4 M Direct
Common Stock Disposition 2023-03-13 600 $56.86 199,185 No 4 S Direct
Common Stock Disposition 2023-03-13 1,300 $58.07 197,885 No 4 S Direct
Common Stock Disposition 2023-03-13 4,600 $59.02 193,285 No 4 S Direct
Common Stock Disposition 2023-03-13 600 $56.90 192,685 No 4 S Direct
Common Stock Disposition 2023-03-13 1,700 $58.27 190,985 No 4 S Direct
Common Stock Disposition 2023-03-13 3,950 $59.06 187,035 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2023-03-12 125,393 $0.00 125,393 $0.00
Common Stock Stock Options (Right to Buy) Disposition 2023-03-13 6,500 $0.00 6,500 $0.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
152,977 2029-04-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,600 Indirect By Spouse
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
  2. This transaction was executed in multiple trades at prices ranging from $56.54 to $57.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $57.55 to $58.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $58.58 to $59.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $56.54 to $57.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $57.66 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $58.66 to $59.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied.
  9. Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.